107 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
, including those relating to patient privacy; determinations by regulatory and administrative governmental authorities which may delay or restrict
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
obligations and oversight impacting Regeneron's Products, research and clinical programs, and business, including those relating to patient privacy
8-K
EX-99.1
ebigzj3 muatdt8
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
ajy7gb8djt1 eqiey2t7
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K
EX-99.1
roq e1a7km7n7
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
EX-99.1
aa74t3f2q wvvweb1
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
8-K
EX-99.1
4mszluyo364kng9eylvj
3 Nov 22
Regeneron Reports Third Quarter 2022 Financial and Operating Results
7:19am
8-K
EX-99.1
kdbx5ix ki
3 Aug 22
Regeneron Reports Second Quarter 2022 Financial and Operating Results
7:08am
SC TO-T/A
EX-99
43hvwhu
31 May 22
Third party tender offer statement (amended)
8:38am